Feature | September 18, 2013

Study Uncovers Value of Mammogram Screening for Younger Women

Photo courtesy of Hologic.

A new analysis has found that most deaths from breast cancer occur in younger women who do not receive regular mammograms. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the study indicates that regular screening before age 50 should be encouraged.

The use of mammograms to prevent breast cancer deaths has been controversial, especially after the United States Preventive Services Task Force proposed in 2009 to limit screening to women aged 50 to 74 years. Studies show varying benefits, and advances in treatment may have diminished the importance of early detection. Blake Cady, M.D., professor of surgery (emeritus) of Harvard Medical School in Boston, and his colleagues set out to provide more definitive information on the value of mammography screening through a technique called "failure analysis." Such analyses look backward from death to discover correlations at diagnosis, rather than looking forward from the start of a study. Only one other failure analysis related to cancer has been published to date. In this analysis, invasive breast cancers diagnosed at Partners HealthCare hospitals in Boston between 1990 and 1999 were followed through 2007. Data for the study included demographics, mammography use, surgical and pathology reports, and recurrence and death dates.

Among 609 confirmed breast cancer deaths, 29 percent were among women who had been screened with mammography, while 71 percent were among unscreened women. Of all breast cancer deaths, only 13 percent occurred in women aged 70 or older, but 50 percent occurred in women under age 50. Among women diagnosed with breast cancer, those who died of the disease were a median of 49 years old at diagnosis; for those dying of any other cause, the median age at diagnosis was 72 years.

"The biological nature of breast cancer in young women is more aggressive, while breast cancer in older women tends to be more indolent. This suggests that less frequent screening in older women, but more frequent screening in younger women, may be more biologically based, practical, and cost effective," said Cady.

This study also showed a dramatic shift in survival from breast cancer associated with the introduction of screening. In 1969, half of women diagnosed with breast cancer had died by 12.5 years after diagnosis. Among the women with invasive breast cancer in this review who were diagnosed between 1990 and 1999, only 9.3 percent had died. "This is a remarkable achievement, and the fact that 71 percent of the women who died were women who were not participating in screening clearly supports the importance of early detection," said co-author Daniel Kopans, M.D., of Harvard Medical School and Massachusetts General Hospital. He added that a number of research articles have inaccurately claimed that screening leads to over diagnosis. "None of these papers have actually looked at individual women but have used registry data, and this has led to false conclusions … This present paper examines each woman as an individual with direct data on who was screened and which women died of breast cancer. It addresses the question from a different and unique perspective."

Related Content

iCAD Appoints Stacey Stevens as President
News | Radiology Business | April 16, 2019
iCAD Inc. recently announced that Stacey Stevens has been named president. As president, Stevens will have expanded...
compressed breast during mammography.
360 Photos | 360 View Photos | April 16, 2019
A 360 view of a simulated breast compression for a...
Check-Cap Initiates U.S. Pilot Study of C-Scan for Colorectal Cancer Screening
News | Colonoscopy Systems | April 15, 2019
Check-Cap Ltd. has initiated its U.S. pilot study of the C-Scan system for prevention of colorectal cancer through...
A smart algorithm has been trained on a neural network to recognize the appearance of breast cancer in MR images

A smart algorithm has been trained on a neural network to recognize the appearance of breast cancer in MR images. The algorithm, described at the SBI/ACR Breast Imaging Symposium, used “Deep Learning,“ a form of machine learning, which is a type of artificial intelligence. Graphic courtesy of Sarah Eskreis-Winkler, M.D.

Feature | Artificial Intelligence | April 12, 2019 | By Greg Freiherr
The use of smart algorithms has the potential to make healthcare more efficient.
This image depicts ABUS images with QVCAD results

This image depicts ABUS images with QVCAD results.

Feature | Breast Imaging | April 12, 2019
Imaging Technology News spoke with Bob Foley, vice president of sales and marketing of QView Medical, Inc.,
Deep Lens Closes Series A Financing for Digital AI Pathology Platform
News | Digital Pathology | April 09, 2019
Digital pathology company Deep Lens Inc. announced the closing of a $14 million Series A financing that will further...
Uterine Fibroid Embolization Safer and as Effective as Surgical Treatment
News | Interventional Radiology | April 05, 2019
Uterine fibroid embolization (UFE) effectively treats uterine fibroids with fewer post-procedure complications compared...
iCAD Highlighting ProFound AI for Tomosynthesis at 2019 SBI Annual Symposium
News | Computer-Aided Detection Software | April 04, 2019
iCAD announced it will present its latest artificial intelligence (AI) software solution for digital breast...